UBS Group’s Future Health ESG Corp. Unit FHLTU Stock Holding History

UBS Group’s Portfolio FHLTU Stock Details FHLTU Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2024 Q2	–	Sell	-24	Closed	-$229	–	10495
2024 Q1	$229	Sell	24 -206	-90%	-$2.2K	﹤0.01%	8710
2023 Q4	$2.12K	Buy	+230	New	+$2.36K	﹤0.01%	8160
2023 Q1	–	Sell	-1,338	Closed	-$12.9K	–	11602
2022 Q4	$12.9K	Hold	1,338	–	–	﹤0.01%	8219
2022 Q3	$14K	Sell	1,338 -200	-13%	-$2.02K	﹤0.01%	7995
2022 Q2	$16K	Buy	1,538 +160	+12%	+$1.6K	﹤0.01%	7266
2022 Q1	$14K	Buy	1,378 +79	+6%	+$791	﹤0.01%	8022
2021 Q4	$13K	Buy	1,299 +1,000	+334%	+$10K	﹤0.01%	8532
2021 Q3	$3K	Buy	+299	New	+$2.97K	﹤0.01%	8917

UBS Group's FHLTU Position: Q2 2024 in Review

UBS Group sold out of Future Health ESG Corp. Unit (FHLTU) in Q2 2024, closing a stake of 24 shares — an estimated $229 sold.

UBS Group first reported a position in FHLTU in Q3 2021 and held it in 8 quarters. The position peaked at $16K in Q2 2022. 0 funds tracked by Wall St. Rank hold FHLTU as of Q2 2024.

UBS Group reported no remaining Future Health ESG Corp. Unit position as of Q2 2024 after selling out during the quarter.
UBS Group sold 24 Future Health ESG Corp. Unit shares in Q2 2024, an estimated $229.
UBS Group first reported a position in Future Health ESG Corp. Unit in Q3 2021 and held it in 8 quarters.
UBS Group's Future Health ESG Corp. Unit position peaked at $16K in Q2 2022.
0 funds tracked by Wall St. Rank held Future Health ESG Corp. Unit as of Q2 2024.

Based on UBS Group's 13F filing for Q2 2024, filed 14 Aug 2024.